Dimensional Fund Advisors
VYNT

Dimensional Fund Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Dimensional Fund Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-132
Closed -$33K – 3388
2018
Q1 		$33K Buy
+132
New +$37.2K ﹤0.01% 3329

Other funds holding VYNT

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Dimensional Fund Advisors's VYNT Position: Q2 2018 in Review

Dimensional Fund Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2018, closing a stake of 132 shares — an estimated $33K sold.

Dimensional Fund Advisors first reported a position in VYNT in Q1 2018 and held it in 1 quarter. The position peaked at $33K in Q1 2018. 23 funds tracked by Wall St. Rank hold VYNT as of Q2 2018.

  • Dimensional Fund Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 132 Vyant Bio, Inc. Common Stock shares in Q2 2018, an estimated $33K.
  • Dimensional Fund Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Dimensional Fund Advisors's Vyant Bio, Inc. Common Stock position peaked at $33K in Q1 2018.
  • 23 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2018.

Based on Dimensional Fund Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.